期刊文献+

HVEM重组腺病毒载体的构建与鉴定 被引量:1

Construction and identification of Adv-mHVEM-IRES2-EGFP.
下载PDF
导出
摘要 目的HVEM突变体和EGFP共表达复制缺陷型腺病毒载体的构建与鉴定。方法RT-PCR获得人HVEM的cDNA,使其与LIGHT分子结合的表位点突变,保留与BTLA结合的关键位点。构建经修饰的HVEM基因的复制缺陷型腺病毒载体Adv-mHVEM-IRES2-EGFP并对其进行鉴定和转染效率测定。结果成功构建HVEM突变体和EGFP复制缺陷型腺病毒载体,经过测序与预期一致。该载体能够表达突变的HVEM和EGFP蛋白,体外培养细胞转染效率达到95%以上。结论构建的腺病毒载体能够共表达目的基因的产物HVEM突变体和EGFP蛋白,对体外细胞具有高效转染能力。 Objective Construction and identification of Adv-mHVEM-IRES2-EGFP.Methods HVEM cDNA bind domain of LIGHT was mutated by RT - PCR and PCR. Adenovirus expression vector Adv-mHVEM-IRES2-EGFP was constructed with mHVEM and EGFP by means of AD-Easy system.The vector was identified and evaluated the efficiency of transfecfion. Results HVEM and EGFP were expressed in the culture cells transfected by the vector whir a transfection efficiency over 95 %. Conclusion The recombinate vector Adv-mHVEM-IRES2-EGFP could express the protein of mHVEM and EGFP in cell line with high transfection efficiency.
出处 《四川医学》 CAS 2006年第7期668-670,共3页 Sichuan Medical Journal
基金 国家自然科学基金资助项目(30571863)
关键词 共刺激信号 HVEM突变体 BTLA腺病毒表达载体 Co-stimulatory signals HVEM Mutant BTLA Adenovirus expression vector
  • 相关文献

参考文献10

  • 1Latchman Y,Wood CR,Chernova T,et al.PD-L2 is a second ligand for PD-1 and inhibits T cell activation[J].Nat Immunol,2001,2:261 ~ 268
  • 2Mauri DN,Ebner R,Montgomery RI,et al.LIGHT,a new member of the TNF superfamily,and lymphotoxin alpha are ligands for herpesvirus entry mediator[J].Immunity,1998,8:21 ~ 30
  • 3Compaan DM,Gonzalez LC,Tom I,et al.Attenuating lymphocyte activity:the crystal structure of the BTLA-HVEM complex[J].J Biol Chem,2005,280:39553 ~ 39561
  • 4Croft M.The evolving crosstalk between co-stimulatory and co-inhibitory receptors:HVEM-BTLA[J].Trends Immunol,2005,7:292 ~ 294
  • 5冯嘉瑜,张艮甫,黄赤兵,王平贤,范明齐.激活T细胞负性共刺激信号对大鼠同种异体肾移植存活的影响[J].四川医学,2006,27(1):4-5. 被引量:5
  • 6Gavrieli M,Watanabe N,Loftin S K,et al.Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2[J].Biochem Biophys Res Commun,2003,188(6):1236 ~ 1243
  • 7赵彦宗,岳中瑾.负性T细胞共刺激分子和移植免疫研究进展[J].国外医学(泌尿系统分册),2005,25(1):64-68. 被引量:6
  • 8Prasad D V,Richards S,Mai X M,et al.B7S1,a novel B7 family member that negatively regulates T cell activation[J].Immunity,2003,126(5):863~873
  • 9Sics G L,Choi I H,Zhu G,et al.B7-H4,a molecule of the B7 family,negatively regulates T cell immunity[J].Immunity,2003,217 (9):849 ~861
  • 10Sedy J R,Gavrieli M,Potter K G,et al.B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator[J].Nat Immunol,2005,322(12):90 ~ 98

二级参考文献36

  • 1冯嘉瑜,张艮甫,王平贤,范明齐,贺伟峰.CD154胞外区基因局部修饰对大鼠移植肾存活的影响[J].第三军医大学学报,2004,26(12):1068-1070. 被引量:5
  • 2王平贤,王安静,黄秀英,方丽,黄赤兵,范明齐,张艮甫.尿转化生长因子β对慢性移植肾肾病影响的研究[J].四川医学,2004,25(12):1284-1286. 被引量:1
  • 3冯嘉瑜,张艮甫,黄赤兵,张寅生,贺伟峰,吴军.改良的大鼠原位肾移植模型的建立[J].第三军医大学学报,2004,26(24):2264-2265. 被引量:12
  • 4Zhang J,Salcedo TW,Wan X,et al.Modulation of T-cell responses to alloantigens by TR6/DcR3.J Clin Invest,2001,107(11):1459-68.
  • 5Wu Y,Han B,Luo H,et al.DcR3/TR6 effectively prevents islet primary nonfunction after transplantation.Diabetes,2003,52(9):2279-86.
  • 6Sandstrom K,Xu Z,Forsberg G,et al.Inhibition of the CD28-CD80 co-stimulation signal by a CD28-binding affibody ligand developed by combinatorial protein engineering.Protein Eng,2003,16(9):691-7.
  • 7Benda B,Ljunggren HG,Peach R,et al.Co-stimulatory molecules in islet xenotransplantation:CTLA4Ig treatment in CD40 ligand-deficient mice.Cell Transplant,2002,11(7):715-20.
  • 8Judge TA,Wu Z,Zheng XG,et al.The role of CD80,CD86,and CTLA4 in alloimmune responses and the induction of long-term allograft survival.J Immunol,1999,162(4):1947-51.
  • 9Vendetti S,Riccomi A,Sacchi A,et al.Cyclic adenosine 5'-monophosphate and calcium induce CD152(CTLA-4) up-regulation in resting CD4+ T lymphocytes.J Immunol,2002,169(11):6231-5.
  • 10Yin L,Schneider H,Rudd CE.Short cytoplasmic SDYMNM segment of CD28 is sufficient to convert CTLA-4 to a positive signaling receptor.J Leukoc Biol,2003,73(1):178-82.

共引文献8

同被引文献10

  • 1姚爱华,王学浩,李相成.T细胞负性共刺激途径及其在免疫耐受诱导中的作用[J].中华器官移植杂志,2005,26(2):126-128. 被引量:2
  • 2赵彦宗,岳中瑾.负性T细胞共刺激分子和移植免疫研究进展[J].国外医学(泌尿系统分册),2005,25(1):64-68. 被引量:6
  • 3毛丽伟,倪兵.B/T淋巴细胞间抑制信号研究进展[J].免疫学杂志,2005,21(B06):46-49. 被引量:5
  • 4Latchman Y,Wood CR,Cbernova T,et al. PDL2 is a second ligand for PD21 and inhibit s T cell activation[J]. Nat Immunol, 2001,2(3) :261.
  • 5Mauri DN, Ebner R, Montgomery RI, et al. LIGHT, a new member of the TNF superfamily, and lymphotoxinalpha are ligands for herpesvirus entry mediator[J]. Immunity, 1998,8(1) :21.
  • 6Compaan DM, Gonzalez LC, TomI, et al. Attenuating lymphocyte activity: the erystal structure of the BTLA HVEM complex[J]. J Biol Chem, 2005,280 : 39553.
  • 7Croft M. The evolving crosstalk between co2stimulatory and coinhibitory receptors: HVEM-BTLA[J]. Trends Immunol,2005,26(6) :292.
  • 8Cheung TC, Humphreys IR, Potter KG, et al. Evolution arily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway[J]. Proc Natl Acad Sci USA, 2005,102 (37): 13218.
  • 9Gavrieli M, Watanabe N, Loftin SK, et al. Characterization of phosphotyrosine binding motif s in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP1 and SHP2[J]. Biochem Biophys Res Commun, 2003,312 (4):1236.
  • 10冯嘉瑜,贺伟峰,朱晓星,宋波,杨康,张银甫,黄赤兵.小鼠异位心脏移植模型的改良[J].中国比较医学杂志,2008,18(3):68-71. 被引量:4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部